C.R. Sincock, II, is executive vice president of Avfuel Corporation, the leading independent and global supplier of aviation fuel and services to all major aviation consumer groups.
Established over 50 years ago, Avfuel is core competent in every aspect that surrounds the delivery of fuel, from refinery to wingtip. It provides global access with personalized service throughout a fueling network of 3,500+ global locations and 675+ branded FBOs.
Sincock leads Avfuel’s focus on next-generation aviation technologies, including strategic partnerships and investments across the spectrum of sustainable aviation fuel pathways (HEFA, alcohol-to-jet, biomass, power-to-liquid, etc.), plus hybrid-electric power solutions.
Offering unique operational expertise, Sincock is also president and CEO of sister-company and FBO chain, Avflight, to provide specific solutions to a broad customer base, including FBO ownership and contract negotiation for airline, cargo and military operations.
Along with an undergraduate degree in economics from Harvard College and an MBA from Harvard Business School, Sincock also earned a master’s degree in biotechnology from Johns Hopkins University. His background at the energy desk at QVT Financial LP, a multi-strategy hedge fund based in New York City, lends to his financial mindset and experience.
Outside the energy sector, Sincock is the founding investor and senior strategic advisor at Kriya Therapeutics, a leading gene therapy company developing long-term cures for diabetes, blindness and other chronic diseases. Sincock lives in both Miami, Florida, and Ann Arbor, Michigan.
All rights reserved